Literature DB >> 29208793

Assessment of Proliferative Potential of Odontogenic Keratocyst and Dentigerous Cyst using Podoplanin: An Immunohistochemical Study.

Sandeep Gupta1, Aparna Paliwal2, Nidhi Choudaha3, Anish Gupta4, Prashant Rao5, Shekhar Grover6.   

Abstract

INTRODUCTION: Odontogenic cysts are commonly encountered lesions among head and neck pathologies. Odontogenic keratocyst (OKC) has unique features of recurrence and local aggressiveness. Podoplanin (PDP) is a lymphatic endothelial marker and is shown to be expressed in a variety of tissues. Hence, we planned to assess the significance of PDP in OKC and dentigerous cyst (DC).
MATERIALS AND METHODS: The present study included assessment of immunoexpression of PDP in OKC and DC. Twenty specimens each of OKC and DC were included in the present study and were stained with D2-40 antibody. All the sections were analyzed and were categorized as negative staining, weakly positive staining, and strongly positive staining. All the results were analyzed by Statistical Package for the Social Sciences (SPSS) software.
RESULTS: We detected PDP-positive staining in the cell membrane and cytoplasm of the cells of basal cell layer and supra-basal cell layers. In DC cases, we observed positive staining only in cases associated with inflammation.
CONCLUSION: Podoplanin does play a significant role in enhancing the local invasive and neoplastic properties of OKC. CLINICAL SIGNIFICANCE: Podoplanin expression in OKC is potentially associated with moderate invasive nature of the neighboring structures.

Entities:  

Keywords:  Dentigerous cyst; Odontogenic keratocyst Podoplanin.

Mesh:

Substances:

Year:  2017        PMID: 29208793     DOI: 10.5005/jp-journals-10024-2194

Source DB:  PubMed          Journal:  J Contemp Dent Pract        ISSN: 1526-3711


  1 in total

1.  Assessment of expression of podoplanin in odontogenic tumors and cysts-An immunohistochemical study.

Authors:  Rohit Singh; Malwika Sisodia; Ranjan Sengupta; Annu Prakash Bhindwar; Karuna Bharti; Md Abu Nafe
Journal:  J Family Med Prim Care       Date:  2020-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.